API | magnesium acetate

magnesium acetate Report issue

Small molecule Approved ^FDA Priority Review ^FDA

ChEMBL DrugBank Drug Central PubChem

Active Ingredient History

NOW

Anhydrous magnesium acetate has the chemical formula Mg(C2H3O2)2 and in its hydrated form, magnesium acetate tetrahydrate, it has the chemical formula Mg(CH3COO)2 • 4H2O. In this compound magnesium has an oxidation state of 2+. Magnesium acetate is the magnesium salt of acetic acid. It is deliquescent and upon heating, it decomposes to form magnesium oxide. Magnesium acetate is commonly used as a source of magnesium in biological reactions. ^Wikipedia

Chemistry

SMILES: O.O.O.O.[Mg+2].CC(=O)[O-].CC(=O)[O-]
InChIKey: XKPKPGCRSHFTKM-UHFFFAOYSA-L
Mol. Mass: 214.45
ALogP: Missing data
ChEMBL Molecules:

magnesium acetate tetrahydrate

magnesium acetate

None

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Prescription Only
Delivery Methods: Parenteral
Pro Drug: No

Combination drugs

aminosyn m ( phosphoric acid (Freamine), amino acids (Freamine), potassium acetate, magnesium acetate, sodium chloride )

freamine iii w/ electrolytes ( potassium chloride (klor-con), phosphoric acid (Freamine), sodium acetate, amino acids (Freamine), potassium acetate, magnesium acetate )

normosol-m and dextrose ( potassium acetate, magnesium acetate, sodium chloride, glucose monohydrate - other name: plasma-lyte 56 and dextrose )

procalamine ( glycerin, calcium, potassium chloride (klor-con), phosphoric acid (Freamine), sodium acetate, amino acids (Freamine), magnesium acetate, sodium chloride )

Organizations (8)

Research & Development (5)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (3)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (4)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (4)

Glioma (Phase 2)

Healthy Volunteers (Phase 1)

Pain (Phase 1)

Parkinson Disease (Phase 2/Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 7
# of Trial Organizations: 5

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue